Subversion of host recognition and defense systems by Francisella spp.

Microbiology and Molecular Biology Reviews

Volumn 76, Issue 2, 2012, Pages 383-404

  Jones, Crystal L ^a   Napier, Brooke A ^a   Sampson, Timothy R ^a   Llewellyn, Anna C ^a   Schroeder, Max R ^a   Weiss, David S ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBODY; BETA LACTAM ANTIBIOTIC; CATHELICIDIN; COMPLEMENT; COMPLEMENT MEMBRANE ATTACK COMPLEX; GAMMA INTERFERON; HEPCIDIN; QUINOLONE; REACTIVE OXYGEN METABOLITE; TETRACYCLINE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ACIDIFICATION; ADAPTIVE IMMUNITY; COMPLEMENT ACTIVATION; CYTOSOL; DEFENSE MECHANISM; FRANCISELLA TULARENSIS; GENE MUTATION; HOST; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; KLEBSIELLA; LEGIONELLA PNEUMOPHILA; MACROPHAGE; MOLECULAR RECOGNITION; NEUTROPHIL; NONHUMAN; NUTRITION; PHAGOCYTE; PHAGOCYTOSIS; PHAGOSOME; REVIEW; SALMONELLA; SIGNAL TRANSDUCTION; STATIC ELECTRICITY; STREPTOCOCCUS PNEUMONIAE; WILD TYPE;

ANIMALS; FRANCISELLA TULARENSIS; GENOME, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION MEDIATORS; MICROBIAL VIABILITY; PHAGOSOMES; TULAREMIA;

EID: 84862521854     PISSN: 10922172     EISSN: 10985557     Source Type: Journal    
DOI: 10.1128/MMBR.05027-11     Document Type: Review

References (244)

1. Abplanalp AL, Morris IR, Parida BK, Teale JM, Berton MT. 2009. TLR-dependent control of Francisella tularensis infection and host inflammatory responses. PLoS One 4:e7920.
2. Akimana C, Kwaik Y. 2011. Francisella-arthropod vector interaction and its role in patho-adaptation to infect mammals. Front. Microbiol. 2:34.
3. Alkhuder K, Meibom KL, Dubail I, Dupuis M, Charbit A. 2009. Glutathione provides a source of cysteine essential for intracellular multiplication of Francisella tularensis. PLoS Pathog. 5:e1000284.
4. Allen LA, Beecher BR, Lynch JT, Rohner OV, Wittine LM. 2005. Helicobacter pylori disrupts NADPH oxidase targeting in human neutrophils to induce extracellular superoxide release. J. Immunol. 174:3658-3667.
5. Amer LS, Bishop BM, van Hoek ML. 2010. Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella. Biochem. Biophys. Res. Commun. 396:246-251.
6. Ancuta P, Pedron T, Girard R, Sandstrom G, Chaby R. 1996. Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins. Infect. Immun. 64:2041-2046.
7. Andersson H, et al. 2006. Transcriptional profiling of host responses in mouse lungs following aerosol infection with type A Francisella tularensis. J. Med. Microbiol. 55:263-271.
8. Anthony LS, Skamene E, Kongshavn PA. 1988. Influence of genetic background on host resistance to experimental murine tularemia. Infect. Immun. 56:2089-2093.
9. Apicella MA, et al. 2010. Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis. PLoS One 5:e11060.
10. Appelberg R. 2006. Macrophage nutriprive antimicrobial mechanisms. J. Leukoc. Biol. 79:1117-1128.
11. Asare R, Abu Kwaik Y. 2010. Molecular complexity orchestrates modulation of phagosome biogenesis and escape to the cytosol of macrophages by Francisella tularensis. Environ. Microbiol. 12:2559-2586.
12. Asong J, Wolfert MA, Maiti KK, Miller D, Boons GJ. 2009. Binding and cellular activation studies reveal that Toll-like receptor 2 can differentially recognize peptidoglycan from Gram-positive and Gram-negative bacteria. J. Biol. Chem. 284:8643-8653.
13. Atianand MK, et al. 2011. Francisella tularensis reveals a disparity between human and mouse NLRP3 inflammasome activation. J. Biol. Chem. 286:39033-39042.
14. Babior BM. 2002. The leukocyte NADPH oxidase. Isr. Med. Assoc. J. 4:1023-1024.
15. Bakshi CS, et al. 2008. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain. Vaccine 26:5276-5288.
16. Bakshi CS, et al. 2006. Superoxide dismutase B gene (sodB)-deficient mutants of Francisella tularensis demonstrate hypersensitivity to oxidative stress and attenuated virulence. J. Bacteriol. 188:6443-6448.
17. Balagopal A, et al. 2006. Characterization of the receptor-ligand pathways important for entry and survival of Francisella tularensis in human macrophages. Infect. Immun. 74:5114-5125.
18. Bandara AB, et al. 2011. Isolation and mutagenesis of a capsule-like complex (CLC) from Francisella tularensis, and contribution of the CLC to F. tularensis virulence in mice. PLoS One 6:e19003.
19. Barel M, et al. 2008. A novel receptor-ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu. BMC Microbiol. 8:145.
20. Barker JH, et al. 2009. The role of complement opsonization in interactions between F. tularensis subsp. novicida and human neutrophils. Microbes Infect. 11:762-769.
21. Barker JR, et al. 2009. The Francisella tularensis pathogenicity island encodes a secretion system that is required for phagosome escape and virulence. Mol. Microbiol. 74:1459-1470.
22. Baron GS, Reilly TJ, Nano FE. 1999. The respiratory burst-inhibiting acid phosphatase AcpA is not essential for the intramacrophage growth or virulence of Francisella novicida. FEMS Microbiol. Lett. 176:85-90.
23. Baucheron S, et al. 2004. AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium DT104. Antimicrob. Agents Chemother. 48:3729-3735.
24. Bauler TJ, Chase JC, Bosio CM. 2011. IFN-beta mediates suppression of IL-12p40 in human dendritic cells following infection with virulent Francisella tularensis. J. Immunol. 187:1845-1855.
25. Beasley AS, et al. 2012. A variety of novel lipid a structures obtained from Francisella tularensis live obtained from Francisella tularensis live. Innate Immun. 18:268-278.
26. Beatty WL, Belanger TA, Desai AA, Morrison RP, Byrne GI. 1994. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect. Immun. 62:3705-3711.
27. Beauregard KE, Lee KD, Collier RJ, Swanson JA. 1997. pH-dependent perforation of macrophage phagosomes by listeriolysin O from Listeria monocytogenes. J. Exp. Med. 186:1159-1163.
28. Ben Nasr A, et al. 2006. Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria. J. Leukoc. Biol. 80:774-786.
29. Ben Nasr A, Klimpel GR. 2008. Subversion of complement activation at the bacterial surface promotes serum resistance and opsonophagocytosis of Francisella tularensis. J. Leukoc. Biol. 84:77-85.
30. Bina XR, Lavine CL, Miller MA, Bina JE. 2008. The AcrAB RND efflux system from the live vaccine strain of Francisella tularensis is a multiple drug efflux system that is required for virulence in mice. FEMS Microbiol. Lett. 279:226-233.
31. Birdsell D, et al. 2009. Francisella tularensis subsp. novicida isolated from a human in Arizona. BMC Res. Notes 2:223.
32. Boehm U, Klamp T, Groot M, Howard JC. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:749-795.
33. Boneca IG, et al. 2007. A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system. Proc. Natl. Acad. Sci. U. S. A. 104:997-1002.
34. Bosio CM, Bielefeldt-Ohmann H, Belisle JT. 2007. Active suppression of the pulmonary immune response by Francisella tularensis Schu4. J. Immunol. 178:4538-4547.
35. Bosio CM, Dow SW. 2005. Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J. Immunol. 175:6792-6801.
36. Braun V. 2001. Iron uptake mechanisms and their regulation in pathogenic bacteria. Int. J. Med. Microbiol. 291:67-79.
37. Bridges K, Seligman P. 1995. Disorders of iron metabolism. JB Lippincott Company, London, United Kingdom.
38. Butchar JP, et al. 2008. Microarray analysis of human monocytes infected with Francisella tularensis identifies new targets of host response subversion. PLoS One 3:e2924.
39. Campos M, et al. 2004. Capsule polysaccharide mediates bacterial resistance. Infect. Immun. 72:7107-7114.
40. Carlson PE, Jr, et al. 2009. Global transcriptional response to spermine, a component of the intramacrophage environment, reveals regulation of Francisella gene expression through insertion sequence elements. J. Bacteriol. 191:6855-6864.
41. Cartron ML, Maddocks S, Gillingham P, Craven CJ, Andrews SC. 2006. Feo-transport of ferrous iron into bacteria. Biometals 19:143-157.
42. Cederlund A, Gudmundsson G, Agerberth B. 2011. Antimicrobial peptides important in innate immunity. FEBS J. 278:3942-3951.
43. Champion MD, et al. 2009. Comparative genomic characterization of Francisella tularensis strains belonging to low and high virulence subspecies. PLoS Pathog. 5:e1000459.
44. Chase JC, Celli J, Bosio CM. 2009. Direct and indirect impairment of human dendritic cell function by virulent Francisella tularensis Schu S4. Infect. Immun. 77:180-195.
45. Checroun C, Wehrly TD, Fischer ER, Hayes SF, Celli J. 2006. Autophagy-mediated reentry of Francisella tularensis into the endocytic compartment after cytoplasmic replication. Proc. Natl. Acad. Sci. U. S. A. 103:14578-14583.
46. Chen W, KuoLee R, Shen H, Busa M, Conlan JW. 2004. Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis. Microb. Pathog. 37:185-191.
47. Chen W, Kuolee R, Shen H, Busa M, Conlan JW. 2005. Toll-like receptor 4 (TLR4) plays a relatively minor role in murine defense against primary intradermal infection with Francisella tularensis LVS. Immunol. Lett. 97:151-154.
48. Child R, Wehrly TD, Rockx-Brouwer D, Dorward DW, Celli J. 2010. Acid phosphatases do not contribute to the pathogenesis of type A Francisella tularensis. Infect. Immun. 78:59-67.
49. Chong A, et al. 2008. The early phagosomal stage of Francisella tularensis determines optimal phagosomal escape and Francisella pathogenicity island protein expression. Infect. Immun. 76:5488-5499.
50. Chu P, Rodriguez AR, Arulanandam BP, Klose KE. 2011. Tryptophan prototrophy contributes to Francisella tularensis evasion of gamma interferon-mediated host defense. Infect. Immun. 79:2356-2361.
51. Clay CD, Soni S, Gunn JS, Schlesinger LS. 2008. Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen. J. Immunol. 181:5568-5578.
52. Clemens DL, Lee BY, Horwitz MA. 2005. Francisella tularensis enters macrophages via a novel process involving pseudopod loops. Infect. Immun. 73:5892-5902.
53. Clemens DL, Lee BY, Horwitz MA. 2009. Francisella tularensis phagosomal escape does not require acidification of the phagosome. Infect. Immun. 77:1757-1773.
54. Clinton SR, Bina JE, Hatch TP, Whitt MA, Miller MA. 2010. Binding and activation of host plasminogen on the surface of Francisella tularensis. BMC Microbiol. 10:76.
55. Cole LE, et al. 2007. Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages. Infect. Immun. 75:4127-4137.
56. Collazo CM, Sher A, Meierovics AI, Elkins KL. 2006. Myeloid differentiation factor-88 (MyD88) is essential for control of primary in vivo Francisella tularensis LVS infection, but not for control of intramacrophage bacterial replication. Microbes Infect. 8:779-790.
57. Colquhoun D, Duobu S. 2011. Francisella infections in farmed and wild aquatic organisms. Vet. Res. 42:47.
58. Conlan JW, Chen W, Shen H, Webb A, KuoLee R. 2003. Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies. Microb. Pathog. 34:239-248.
59. Crane DD, Warner SL, Bosio CM. 2009. A novel role for plasmin-mediated degradation of opsonizing antibody in the evasion of host immunity by virulent, but not attenuated, Francisella tularensis. J. Immunol. 183:4593-4600.
60. Cremer TJ, Amer A, Tridandapani S, Butchar JP. 2009. Francisella tularensis regulates autophagy-related host cell signaling pathways. Autophagy 5:125-128.
61. Cremer TJ, et al. 2011. Akt-mediated proinflammatory response of mononuclear phagocytes infected with Burkholderia cenocepacia occurs by a novel GSK3β-dependent, IκB kinase-independent mechanism. J. Immunol. 187:635-643.
62. Culkin SJ, Rhinehart-Jones T, Elkins KL. 1997. A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J. Immunol. 158:3277-3284.
63. Cyktor JC, Turner J. 2011. Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens. Infect. Immun. 79:2964-2973.
64. de Bruin OM, et al. 2011. The biochemical properties of the Francisella pathogenicity island (FPI)-encoded proteins IglA, IglB, IglC, PdpB and DotU suggest roles in type VI secretion. Microbiology 157:3483-3491.
65. de Bruin OM, Ludu JS, Nano FE. 2007. The Francisella pathogenicity island protein IglA localizes to the bacterial cytoplasm and is needed for intracellular growth. BMC Microbiol. 7:1.
66. Decker T, Muller M, Stockinger S. 2005. The yin and yang of type I interferon activity in bacterial infection. Nat. Rev. Immunol. 5:675-687.
67. Deng K, Blick R, Liu W, Hansen E. 2006. Identification of Francisella tularensis genes affected by iron limitation. Infect. Immun. 74:4224-4236.
68. De Pascalis R, Taylor BC, Elkins KL. 2008. Diverse myeloid and lymphoid cell subpopulations produce gamma interferon during early innate immune responses to Francisella tularensis live vaccine strain. Infect. Immun. 76:4311-4321.
69. Deretic V, Levine B. 2009. Autophagy, immunity, and microbial adaptations. Cell Host Microbe 5:527-549.
70. Desvaux M, Hébraud M. 2006. The protein secretion systems in Listeria: inside out bacterial virulence. FEMS Microbiol. Rev. 30:774-805.
71. Drysdale M, et al. 2005. Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax. EMBO J. 24:221-227.
72. Duenas AI, et al. 2006. Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptor 4 with much lower potency than E. coli LPS. Int. Immunol. 18:785-795.
73. Dziarski R, Gupta D. 2005. Staphylococcus aureus peptidoglycan is a Toll-like receptor 2 activator: a reevaluation. Infect. Immun. 73:5212-5216.
74. Edwards JA, Rockx-Brouwer D, Nair V, Celli J. 2010. Restricted cytosolic growth of Francisella tularensis subsp. tularensis by IFN-gamma activation of macrophages. Microbiology 156:327-339.
75. Elkins KL, Cooper A, Colombini SM, Cowley SC, Kieffer TL. 2002. In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70. Infect. Immun. 70:1936-1948.
76. Elkins KL, Rhinehart-Jones TR, Culkin SJ, Yee D, Winegar RK. 1996. Minimal requirements for murine resistance to infection with Francisella tularensis LVS. Infect. Immun. 64:3288-3293.
77. Elkins KL, Rhinehart-Jones TR, Stibitz S, Conover JS, Klinman DM. 1999. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162:2291-2298.
78. Elser B, et al. 2002. IFN-gamma represses IL-4 expression via IRF-1 and IRF-2. Immunity 17:703-712.
79. Eneslatt K, et al. 2011. Persistence of cell-mediated immunity three decades after vaccination with the live vaccine strain of Francisella tularensis. Eur. J. Immunol. 41:974-980.
80. Fadok VA, et al. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101:890-898.
81. Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES. 2009. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458:509-513.
82. Fernandes-Alnemri T, et al. 2010. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat. Immunol. 11:385-393.
83. Fillatreau S. 2011. Novel regulatory functions for Toll-like receptor-activated B cells during intracellular bacterial infection. Immunol. Rev. 240:52-71.
84. Fink SL, Cookson BT. 2005. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect. Immun. 73:1907-1916.
85. Fontenot JD, Rudensky AY. 2005. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6:331-337.
86. Forestal CA, et al. 2008. A conserved and immunodominant lipoprotein of Francisella tularensis is proinflammatory but not essential for virulence. Microb. Pathog. 44:512-523.
87. Forestal CA, et al. 2007. Francisella tularensis has a significant extracellular phase in infected mice. J. Infect. Dis. 196:134-137.
88. Fujita T, Matsushita M, Endo Y. 2004. The lectin-complement pathway - its role in innate immunity and evolution. Immunol. Rev. 198:185-202.
89. Gallois A, Klein JR, Allen LA, Jones BD, Nauseef WM. 2001. Salmonella pathogenicity island 2-encoded type III secretion system mediates exclusion of NADPH oxidase assembly from the phagosomal membrane. J. Immunol. 166:5741-5748.
90. Geier H, Celli J. 2011. Phagocytic receptors dictate phagosomal escape and intracellular proliferation of Francisella tularensis. Infect. Immun. 79:2204-2214.
91. Gil H, et al. 2006. Deletion of TolC orthologs in Francisella tularensis identifies roles in multidrug resistance and virulence. Proc. Natl. Acad. Sci. U. S. A. 103:12897-12902.
92. Golovliov I, Baranov V, Krocova Z, Kovarova H, Sjöstedt A. 2003. An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells. Infect. Immun. 71:5940-5950.
93. Gordon S, Martinez FO. 2010. Alternative activation of macrophages: mechanism and functions. Immunity 32:593-604.
94. Gunn JS, Ernst RK. 2007. The structure and function of Francisella lipopolysaccharide. Ann. N. Y. Acad. Sci. 1105:202-218.
95. Hagman KE, et al. 1995. Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology 141:611-622.
96. Hajjar AM, et al. 2006. Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors. Infect. Immun. 74:6730-6738.
97. Hall JD, et al. 2008. Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infect. Immun. 76:5843-5852.
98. Han S, Bishop BM, van Hoek ML. 2008. Antimicrobial activity of human beta-defensins and induction by Francisella. Biochem. Biophys. Res. Commun. 371:670-674.
99. Henry T, Brotcke A, Weiss DS, Thompson LJ, Monack DM. 2007. Type I interferon signaling is required for activation of the inflammasome during Francisella infection. J. Exp. Med. 204:987-994.
100. Hirakata Y, et al. 2002. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J. Exp. Med. 196:109-118.
101. Hornung V, et al. 2009. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458:514-518.
102. Horwitz MA. 1982. Phagocytosis of microorganisms. Rev. Infect. Dis. 4:104-123.
103. Horwitz MA. 1984. Phagocytosis of the Legionnaires' disease bacterium (Legionella pneumophila) occurs by a novel mechanism: engulfment within a pseudopod coil. Cell 36:27-33.
104. Hoyal CR, et al. 2003. Modulation of p47PHOX activity by site-specific phosphorylation: Akt-dependent activation of the NADPH oxidase. Proc. Natl. Acad. Sci. U. S. A. 100:5130-5135.
105. Hrstka R, et al. 2007. Francisella tularensis strain LVS resides in MHC II-positive autophagic vacuoles in macrophages. Folia Microbiol. (Praha) 52:631-636.
106. Huang MT, et al. 2010. Deletion of ripA alleviates suppression of the inflammasome and MAPK by Francisella tularensis. J. Immunol. 185:5476-5485.
107. Ishikawa H, Ma Z, Barber GN. 2009. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461:788-792.
108. Ishimoto H, et al. 2006. Identification of hBD-3 in respiratory tract and serum: the increase in pneumonia. Eur. Respir. J. 27:253-260.
109. Janeway CA, Jr, Medzhitov R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216.
110. Jia Q, et al. 2010. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge. Infect. Immun. 78:4341-4355.
111. Jones CL, Weiss DS. 2011. TLR2 signaling contributes to rapid inflammasome activation during F. novicida infection. PLoS One 6:e20609.
112. Jones JW, et al. 2010. Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proc. Natl. Acad. Sci. U. S. A. 107:9771-9776.
113. Kang PB, et al. 2005. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J. Exp. Med. 202:987-999.
114. Kanistanon D, et al. 2008. A Francisella mutant in lipid A carbohydrate modification elicits protective immunity. PLoS Pathog. 4:e24.
115. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11:373-384.
116. Kieffer TL, Cowley S, Nano FE, Elkins KL. 2003. Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis. Microbes Infect. 5:397-403.
117. Kiss K, Liu W, Huntley JF, Norgard MV, Hansen EJ. 2008. Characterization of fig operon mutants of Francisella novicida U112. FEMS Microbiol. Lett. 285:270-277.
118. Kofoed EM, Vance RE. 2011. Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 477:592-595.
119. Krocova Z, et al. 2008. Interaction of B cells with intracellular pathogen Francisella tularensis. Microb. Pathog. 45:79-85.
120. Lai XH, Golovliov I, Sjostedt A. 2001. Francisella tularensis induces cytopathogenicity and apoptosis in murine macrophages via a mechanism that requires intracellular bacterial multiplication. Infect. Immun. 69:4691-4694.
121. Laird MH, et al. 2009. TLR4/MyD88/PI3K interactions regulate TLR4 signaling. J. Leukoc. Biol. 85:966-977.
122. Larsson P, et al. 2005. The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat. Genet. 37:153-159.
123. Law HT, et al. 2011. Francisella tularensis uses cholesterol and clathrin-based endocytic mechanisms to invade hepatocytes. Sci. Rep. 1:192.
124. Lee VT, Tam C, Schneewind O. 2000. LcrV, a substrate for Yersinia enterocolitica type III secretion, is required for toxin targeting into the cytosol of HeLa cells. J. Biol. Chem. 275:36869-36875.
125. Leelaporn A, Yongyod S, Limsrivanichakorn S, Yungyuen T, Kiratisin P. 2008. Francisella novicida bacteremia, Thailand. Emerg. Infect. Dis. 14:1935-1937.
126. Leiby DA, Fortier AH, Crawford RM, Schreiber RD, Nacy CA. 1992. In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies. Infect. Immun. 60:84-89.
127. Levine B, Mizushima N, Virgin HW. 2011. Autophagy in immunity and inflammation. Nature 469:323-335.
128. Li H, Nookala S, Bina XR, Bina JE, Re F. 2006. Innate immune response to Francisella tularensis is mediated by TLR2 and caspase-1 activation. J. Leukoc. Biol. 80:766-773.
129. Li J, et al. 2007. Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS. Microbiology 153:3141-3153.
130. Lindemann SR, et al. 2011. Francisella tularensis Schu S4 O-antigen and capsule biosynthesis gene mutants induce early cell death in human macrophages. Infect. Immun. 79:581-594.
131. Lindgren H, et al. 2004. Factors affecting the escape of Francisella tularensis from the phagolysosome. J. Med. Microbiol. 53:953-958.
132. Lindgren H, et al. 2009. The 58-kilodalton major virulence factor of Francisella tularensis is required for efficient utilization of iron. Infect. Immun. 77:4429-4436.
133. 2-induced killing. Infect. Immun. 79:1218-1224.
134. Lindgren H, et al. 2007. Resistance of Francisella tularensis strains against reactive nitrogen and oxygen species with special reference to the role of KatG. Infect. Immun. 75:1303-1309.
135. Llewellyn AC, Jones CL, Napier BA, Bina JE, Weiss DS. 2011. Macrophage replication screen identifies a novel Francisella hydroperoxide resistance protein involved in virulence. PLoS One 6:e24201.
136. Long GW, et al. 1993. Detection of Francisella tularensis in blood by polymerase chain reaction. J. Clin. Microbiol. 31:152-154.
137. Lucas MA, Fretto LJ, McKee PA. 1983. The binding of human plasminogen to fibrin and fibrinogen. J. Biol. Chem. 258:4249-4256.
138. Macela A, et al. 1996. The immune response against Francisella tularensis live vaccine strain in Lps(n) and Lps(d) mice. FEMS Immunol. Med. Microbiol. 13:235-238.
139. Mahnke K, Schmitt E, Bonifaz L, Enk AH, Jonuleit H. 2002. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol. Cell Biol. 80:477-483.
140. Maier TM, et al. 2007. Identification of Francisella tularensis Himar1-based transposon mutants defective for replication in macrophages. Infect. Immun. 75:5376-5389.
141. Mariathasan S, Weiss DS, Dixit VM, Monack DM. 2005. Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J. Exp. Med. 202:1043-1049.
142. Mariathasan S, et al. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228-232.
143. Marshall JG, et al. 2001. Restricted accumulation of phosphatidylinositol 3-kinase products in a plasmalemmal subdomain during Fc gamma receptor-mediated phagocytosis. J. Cell Biol. 153:1369-1380.
144. Martinon F, Mayor A, Tschopp J. 2009. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27:229-265.
145. McCaffrey RL, Allen LA. 2006. Francisella tularensis LVS evades killing by human neutrophils via inhibition of the respiratory burst and phagosome escape. J. Leukoc. Biol. 80:1224-1230.
146. McCaffrey RL, et al. 2010. Multiple mechanisms of NADPH oxidase inhibition by type A and type B Francisella tularensis. J. Leukoc. Biol. 88:791-805.
147. McCoy GW. 1911. Some features of the squirrel plague problem. Cal. State J. Med. 9:105-109.
148. Medina EA, Morris IR, Berton MT. 2010. Phosphatidylinositol 3-kinase activation attenuates the TLR2-mediated macrophage proinflammatory cytokine response to Francisella tularensis live vaccine strain. J. Immunol. 185:7562-7572.
149. Meibom KL, Charbit A. 2010. Francisella tularensis metabolism and its relation to virulence. Front. Microbiol. 1:140.
150. Melillo AA, Bakshi CS, Melendez JA. 2010. Francisella tularensis antioxidants harness reactive oxygen species to restrict macrophage signaling and cytokine production. J. Biol. Chem. 285:27553-27560.
151. Melillo AA, et al. 2009. Identification of Francisella tularensis live vaccine strain CuZn superoxide dismutase as critical for resistance to extracellularly generated reactive oxygen species. J. Bacteriol. 191:6447-6456.
152. Miao EA, et al. 2010. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc. Natl. Acad. Sci. U. S. A. 107:3076-3080.
153. Michell S, et al. 2010. Deletion of the Bacillus anthracis capB homologue in Francisella tularensis subspecies tularensis generates an attenuated strain that protects mice against virulent tularaemia. J. Med. Microbiol. 59:1275-1284.
154. Miethke M, Marahiel MA. 2007. Siderophore-based iron acquisition and pathogen control. Microbiol. Mol. Biol. Rev. 71:413-451.
155. Mohapatra NP, et al. 2010. Francisella acid phosphatases inactivate the NADPH oxidase in human phagocytes. J. Immunol. 184:5141-5150.
156. Mohapatra NP, et al. 2008. Combined deletion of four Francisella novicida acid phosphatases attenuates virulence and macrophage vacuolar escape. Infect. Immun. 76:3690-3699.
157. Monroe KM, McWhirter SM, Vance RE. 2010. Induction of type I interferons by bacteria. Cell. Microbiol. 12:881-890.
158. Mulero V, Brock JH. 1999. Regulation of iron metabolism in murine J774 macrophages: role of nitric oxide-dependent and -independent pathways following activation with gamma interferon and lipopolysaccharide. Blood 94:2383-2389.
159. Murray P, Rosentthal K, Pfaller M. 2005. Medical microbiology, 5th ed. Elsevier Mosby, Philadelphia, PA.
160. Nallaparaju KC, et al. 31 March 2011. Evasion of IFN-γ signaling by Francisella novicida is dependent upon Francisella outer membrane protein C. PLoS One 6:e18201.
161. Nano FE, Schmerk C. 2007. The Francisella pathogenicity island. Ann. N. Y. Acad. Sci. 1105:122-137.
162. Nauseef WM. 2004. Assembly of the phagocyte NADPH oxidase. Histochem. Cell Biol. 122:277-291.
163. Nemeth E, et al. 2004. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090-2093.
164. Neves P, et al. 2010. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 33:777-790.
165. O'Farrell AM, Liu Y, Moore KW, Mui AL. 1998. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways. EMBO J. 17:1006-1018.
166. Pan X, Tamilselvam B, Hansen EJ, Daefler S. 2010. Modulation of iron homeostasis in macrophages by bacterial intracellular pathogens. BMC Microbiol. 10:64.
167. Parsa KV, et al. 2008. Francisella gains a survival advantage within mononuclear phagocytes by suppressing the host IFNgamma response. Mol. Immunol. 45:3428-3437.
168. Parsa KV, et al. 2006. Macrophage pro-inflammatory response to Francisella novicida infection is regulated by SHIP. PLoS Pathog. 2:e71.
169. Parsot C. 1994. Shigella flexneri: genetics of entry and intercellular dissemination in epithelial cells. Curr. Top. Microbiol. Immunol. 192:217-241.
170. Pechous R, et al. 2006. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain. Infect. Immun. 74:4452-4461.
171. Pekarek RS, Bostian KA, Bartelloni PJ, Calia FM, Beisel WR. 1969. The effects of Francisella tularensis infection on iron metabolism in man. Am. J. Med. Sci. 258:14-25.
172. Peng K, Broz P, Jones J, Joubert LM, Monack D. 2011. Elevated AIM2-mediated pyroptosis triggered by hypercytotoxic Francisella mutant strains is attributed to increased intracellular bacteriolysis. Cell Microbiol. 13:1586-1600.
173. Peng K, Monack DM. 2010. Indoleamine 2,3-dioxygenase 1 is a lung-specific innate immune defense mechanism that inhibits growth of Francisella tularensis tryptophan auxotrophs. Infect. Immun. 78:2723-2733.
174. Periasamy S, et al. 2011. Development of tolerogenic dendritic cells and regulatory T cells favors exponential bacterial growth and survival during early respiratory tularemia. J. Leukoc. Biol. 90:493-507.
175. Philpott DJ, Girardin SE. 2010. Nod-like receptors: sentinels at host membranes. Curr. Opin. Immunol. 22:428-434.
176. Phipps RP, Stein SH, Roper RL. 1991. A new view of prostaglandin E regulation of the immune response. Immunol. Today 12:349-352.
177. Pierini LM. 2006. Uptake of serum-opsonized Francisella tularensis by macrophages can be mediated by class A scavenger receptors. Cell. Microbiol. 8:1361-1370.
178. Pilatz S, et al. 2006. Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence. Infect. Immun. 74:3576-3586.
179. Platz GJ, et al. 2010. A tolC mutant of Francisella tularensis is hypercytotoxic compared to the wild type and elicits increased proinflammatory responses from host cells. Infect. Immun. 78:1022-1031.
180. Poole K, Krebes K, McNally C, Neshat S. 1993. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175:7363-7372.
181. Raetz CR, et al. 2009. Discovery of new biosynthetic pathways: the lipid A story. J. Lipid Res. 50(Suppl.):S103-S108.
182. Rajaram MV, et al. 2009. Akt and SHIP modulate Francisella escape from the phagosome and induction of the Fas-mediated death pathway. PLoS One 4:e7919.
183. Ramakrishnan G, Meeker A, Dragulev B. 2008. fslE is necessary for siderophore-mediated iron acquisition in Francisella tularensis Schu S4. J. Bacteriol. 190:5353-5361.
184. Rathinam VA, et al. 2010. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 11:395-402.
185. Ray K, Marteyn B, Sansonetti PJ, Tang CM. 2009. Life on the inside: the intracellular lifestyle of cytosolic bacteria. Nat. Rev. Microbiol. 7:333-340.
186. Recalcati S, Taramelli D, Conte D, Cairo G. 1998. Nitric oxidemediated induction of ferritin synthesis in J774 macrophages by inflammatory cytokines: role of selective iron regulatory protein-2 downregulation. Blood 91:1059-1066.
187. Reilly TJ, Baron GS, Nano FE, Kuhlenschmidt MS. 1996. Characterization and sequencing of a respiratory burst-inhibiting acid phosphatase from Francisella tularensis. J. Biol. Chem. 271:10973-10983.
188. Roberts TL, et al. 2009. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323:1057-1060.
189. Rohmer L, et al. 2007. Comparison of Francisella tularensis genomes reveals evolutionary events associated with the emergence of human pathogenic strains. Genome Biol. 8:R102.
190. Roth KM, Gunn JS, Lafuse W, Satoskar AR. 2009. Francisella inhibits STAT1-mediated signaling in macrophages and prevents activation of antigen-specific T cells. Int. Immunol. 21:19-28.
191. Rus H, Cudrici C, Niculescu F. 2005. The role of the complement system in innate immunity. Immunol. Res. 33:103-112.
192. Russo BC, et al. 2011. A Francisella tularensis locus required for spermine responsiveness is necessary for virulence. Infect. Immun. 79:3665-3676.
193. Sandstrom G, Lofgren S, Tarnvik A. 1988. A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect. Immun. 56:1194-1202.
194. Sansonetti PJ, Ryter A, Clerc P, Maurelli AT, Mounier J. 1986. Multiplication of Shigella flexneri within HeLa cells: lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis. Infect. Immun. 51:461-469.
195. Santic M, Asare R, Skrobonja I, Jones S, Abu Kwaik Y. 2008. Acquisition of the vacuolar ATPase proton pump and phagosome acidification are essential for escape of Francisella tularensis into the macrophage cytosol. Infect. Immun. 76:2671-2677.
196. Santic M, Molmeret M, Abu Kwaik Y. 2005. Modulation of biogenesis of the Francisella tularensis subsp. novicida-containing phagosome in quiescent human macrophages and its maturation into a phagolysosome upon activation by IFN-gamma. Cell. Microbiol. 7:957-967.
197. Santic M, Molmeret M, Klose KE, Jones S, Kwaik YA. 2005. The Francisella tularensis pathogenicity island protein IglC and its regulator MglA are essential for modulating phagosome biogenesis and subsequent bacterial escape into the cytoplasm. Cell. Microbiol. 7:969-979.
198. Sasakawa C, et al. 1989. Functional organization and nucleotide sequence of virulence region-2 on the large virulence plasmid in Shigella flexneri 2a. Mol. Microbiol. 3:1191-1201.
199. Schaller-Bals S, Schulze A, Bals R. 2002. Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. Am. J. Respir. Crit. Care Med. 165:992-995.
200. Schlesinger LS, Bellinger-Kawahara CG, Payne NR, Horwitz MA. 1990. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J. Immunol. 144:2771-2780.
201. Schlesinger LS, Horwitz MA. 1990. Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum. J. Clin. Invest. 85:1304-1314.
202. Schroder K, Hertzog PJ, Ravasi T, Hume DA. 2004. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75:163-189.
203. Schulert GS, Allen LA. 2006. Differential infection of mononuclear phagocytes by Francisella tularensis: role of the macrophage mannose receptor. J. Leukoc. Biol. 80:563-571.
204. Schulert GS, et al. 2009. Francisella tularensis genes required for inhibition of the neutrophil respiratory burst and intramacrophage growth identified by random transposon mutagenesis of strain LVS. Infect. Immun. 77:1324-1336.
205. Sebastian S, et al. 2007. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Infect. Immun. 75:2591-2602.
206. Sen B, Meeker A, Ramakrishnan G. 2010. The fslE homolog, FTL-0439 (fupA/B), mediates siderophore-dependent iron uptake in Francisella tularensis LVS. Infect. Immun. 78:4276-4285.
207. Shi CS, et al. 2012. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat. Immunol. 13:255-263.
208. Shirey KA, Cole LE, Keegan AD, Vogel SN. 2008. Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism. J. Immunol. 181:4159-4167.
209. Sing A, et al. 2002. Yersinia V-antigen exploits Toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J. Exp. Med. 196:1017-1024.
210. Sjöstedt A. 2007. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann. N. Y. Acad. Sci. 1105:1-29.
211. Sjostedt A, Conlan JW, North RJ. 1994. Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection. Infect. Immun. 62:2779-2783.
212. Sorokin VM, Pavlovich NV, Prozorova LA. 1996. Francisella tularensis resistance to bactericidal action of normal human serum. FEMS Immunol. Med. Microbiol. 13:249-252.
213. Stinavage P, Martin L, Spitznagel J. 1989. O antigen and lipid A phosphoryl groups in resistance of Salmonella typhimurium LT-2 to nonoxidative killing in human polymorphonuclear neutrophils. Infect. Immun. 57:3894-3900.
214. Su J, et al. 2011. The capBCA locus is required for intracellular growth of Francisella tularensis LVS. Front. Microbiol. 2:83.
215. Su J, et al. 2007. Genome-wide identification of Francisella tularensis virulence determinants. Infect. Immun. 75:3089-3101.
216. Sullivan JT, Jeffery EF, Shannon JD, Ramakrishnan G. 2006. Characterization of the siderophore of Francisella tularensis and role of fslA in siderophore production. J. Bacteriol. 188:3785-3795.
217. Takeda K, Akira S. 2004. TLR signaling pathways. Semin. Immunol. 16:3-9.
218. Tamilselvam B, Daefler S. 2008. Francisella targets cholesterol-rich host cell membrane domains for entry into macrophages. J. Immunol. 180:8262-8271.
219. Taylor MW, Feng GS. 1991. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 5:2516-2522.
220. Telepnev M, Golovliov I, Grundstrom T, Tarnvik A, Sjostedt A. 2003. Francisella tularensis inhibits Toll-like receptor-mediated activation of intracellular signalling and secretion of TNF-alpha and IL-1 from murine macrophages. Cell. Microbiol. 5:41-51.
221. Thakran S, et al. 2008. Identification of Francisella tularensis lipoproteins that stimulate the Toll-like receptor (TLR) 2/TLR1 heterodimer. J. Biol. Chem. 283:3751-3760.
222. Thomas RM, et al. 2007. The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens. Infect. Immun. 75:371-378.
223. Travassos LH, et al. 2004. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep. 5:1000-1006.
224. Twine S, et al. 2005. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Infect. Immun. 73:8345-8352.
225. Ulland TK, et al. 2010. Mutation of Francisella tularensis mviN leads to increased macrophage absent in melanoma 2 inflammasome activation and a loss of virulence. J. Immunol. 185:2670-2674.
226. Underhill DM, Ozinsky A. 2002. Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 20:825-852.
227. Virgin HW, Levine B. 2009. Autophagy genes in immunity. Nat. Immunol. 10:461-470.
228. Wandersman C, Delepelaire P. 1990. TolC, an Escherichia coli outer membrane protein required for hemolysin secretion. Proc. Natl. Acad. Sci. U. S. A. 87:4776-4780.
229. Wandersman C, Stojiljkovic I. 2000. Bacterial heme sources: the role of heme, hemoprotein receptors and hemophores. Curr. Opin. Microbiol. 3:215-220.
230. Wang X, Ribeiro AA, Guan Z, Abraham SN, Raetz CR. 2007. Attenuated virulence of a Francisella mutant lacking the lipid A 4′-phosphatase. Proc. Natl. Acad. Sci. U. S. A. 104:4136-4141.
231. Wang X, et al. 2006. Structure and biosynthesis of free lipid A molecules that replace lipopolysaccharide in Francisella tularensis subsp. novicida. Biochemistry 45:14427-14440.
232. Weinberg ED. 1974. Iron and susceptibility to infectious disease. Science 184:952-956.
233. Weiss DS, et al. 2007. In vivo negative selection screen identifies genes required for Francisella virulence. Proc. Natl. Acad. Sci. U. S. A. 104:6037-6042.
234. Whitnack E, Beachey EH. 1985. Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein. J. Exp. Med. 162:1983-1997.
235. Wickstrum JR, et al. 2009. Francisella tularensis induces extensive caspase-3 activation and apoptotic cell death in the tissues of infected mice. Infect. Immun. 77:4827-4836.
236. Wilson JE, Katkere B, Drake JR. 2009. Francisella tularensis induces ubiquitin-dependent major histocompatibility complex class II degradation in activated macrophages. Infect. Immun. 77:4953-4965.
237. Woolard MD, et al. 2007. Francisella tularensis-infected macrophages release prostaglandin E2 that blocks T cell proliferation and promotes a Th2-like response. J. Immunol. 178:2065-2074.
238. Yoshida R, Hayaishi O. 1978. Induction of pulmonary indoleamine 2,3-dioxygenase by intraperitoneal injection of bacterial lipopolysaccharide. Proc. Natl. Acad. Sci. U. S. A. 75:3998-4000.
239. Yoshida R, Oku T, Imanishi J, Kishida T, Hayaishi O. 1986. Interferon: a mediator of indoleamine 2,3-dioxygenase induction by lipopolysaccharide, poly(I) X poly(C), and pokeweed mitogen in mouse lung. Arch. Biochem. Biophys. 249:596-604.
240. Yu JJ, et al. 2008. The presence of infectious extracellular Francisella tularensis subsp. novicida in murine plasma after pulmonary challenge. Eur. J. Clin. Microbiol. Infect. Dis. 27:323-325.
241. Zarrella TM, et al. 2011. Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity. PLoS One 6:e22335.
242. Zegarra-Moran O, et al. 2004. Double mechanism for apical tryptophan depletion in polarized human bronchial epithelium. J. Immunol. 173:542-549.
243. Zhao J, et al. 2006. IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways. J. Biol. Chem. 281:10073-10080.
244. Zhao J, Raetz CR. 2010. A two-component Kdo hydrolase in the inner membrane of Francisella novicida. Mol. Microbiol. 78:820-836.